Creekmur Asset Management’s AstraZeneca AZN Stock Holding History

Creekmur Asset Management’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	$17.8K	Sell	116 -1	-0.9%	-$151	﹤0.01%	451
2025 Q2	$16.4K	Hold	117	–	–	﹤0.01%	463
2025 Q1	$17.2K	Sell	117 -28	-19%	-$4.05K	﹤0.01%	418
2024 Q4	$18.9K	Hold	145	–	–	﹤0.01%	349
2024 Q3	$22.5K	Hold	145	–	–	0.01%	331
2024 Q2	$22.5K	Buy	145 +5	+4%	+$752	0.01%	358
2024 Q1	$18.9K	Buy	140 +117	+509%	+$15.5K	0.01%	386
2023 Q4	$3.03K	Buy	+23	New	+$2.99K	﹤0.01%	651

Other funds holding AZN

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Creekmur Asset Management's AZN Position: Q3 2025 in Review

Creekmur Asset Management reduced its AstraZeneca (AZN) stake by 0.85% in Q3 2025, selling an estimated $151 and leaving 116 shares worth $17.8K. The position accounts for ﹤0.01% of the portfolio, ranked #451.

Creekmur Asset Management first reported a position in AZN in Q4 2023 and has held it in 8 quarters since. The position peaked at $22.5K in Q2 2024. 1,289 funds tracked by Wall St. Rank hold AZN as of Q3 2025.

Creekmur Asset Management held 116 shares of AstraZeneca worth $17.8K as of Q3 2025.
Creekmur Asset Management sold 1 AstraZeneca share in Q3 2025, an estimated $151.
AstraZeneca made up ﹤0.01% of Creekmur Asset Management's portfolio in Q3 2025, its #451 holding.
Creekmur Asset Management first reported a position in AstraZeneca in Q4 2023 and has held it in 8 quarters since.
Creekmur Asset Management's AstraZeneca position peaked at $22.5K in Q2 2024.
1,289 funds tracked by Wall St. Rank held AstraZeneca as of Q3 2025.

Based on Creekmur Asset Management's 13F filing for Q3 2025, filed 12 Nov 2025.